These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9666177)

  • 21. Synergistic fungicidal activity of the lipopeptide bacillomycin D with amphotericin B against pathogenic Candida species.
    Tabbene O; Di Grazia A; Azaiez S; Ben Slimene I; Elkahoui S; Alfeddy MN; Casciaro B; Luca V; Limam F; Mangoni ML
    FEMS Yeast Res; 2015 Jun; 15(4):fov022. PubMed ID: 25956541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
    Cao B; Tsang PW; Tsang DN; Samaranayake LP; Wang J
    Microbios; 1996; 87(352):161-7. PubMed ID: 9050253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylenic acids inhibiting azole-resistant Candida albicans from Pentagonia gigantifolia.
    Li XC; Jacob MR; ElSohly HN; Nagle DG; Smillie TJ; Walker LA; Clark AM
    J Nat Prod; 2003 Aug; 66(8):1132-5. PubMed ID: 12932143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanism of overcoming multidrug resistance (MDR) of fungi by amphotericin B and its derivatives.
    Slisz M; Cybulska B; Grzybowska J; Czub J; Prasad R; Borowski E
    J Antibiot (Tokyo); 2007 Jul; 60(7):436-46. PubMed ID: 17721002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thailandins A and B, New Polyene Macrolactone Compounds Isolated from Actinokineospora bangkokensis Strain 44EHW(T), Possessing Antifungal Activity against Anthracnose Fungi and Pathogenic Yeasts.
    Intra B; Greule A; Bechthold A; Euanorasetr J; Paululat T; Panbangred W
    J Agric Food Chem; 2016 Jun; 64(25):5171-9. PubMed ID: 27267862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New N-alkyl derivatives of amphotericin B. Synthesis and biological properties.
    Czerwiński A; König WA; Zieniawa T; Sowiński P; Sinnwell V; Milewski S; Borowski E
    J Antibiot (Tokyo); 1991 Sep; 44(9):979-84. PubMed ID: 1938621
    [No Abstract]   [Full Text] [Related]  

  • 27. A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity.
    Palacios DS; Anderson TM; Burke MD
    J Am Chem Soc; 2007 Nov; 129(45):13804-5. PubMed ID: 17956100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of SPA-S-843 in vitro activity against filamentous fungi.
    Rimaroli C; Bruzzese T
    Chemotherapy; 2000; 46(1):28-35. PubMed ID: 10601795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro susceptibilities of Zygomycota to polyenes.
    Dannaoui E; Meis JF; Mouton JW; Verweij PE;
    J Antimicrob Chemother; 2002 May; 49(5):741-4. PubMed ID: 12003966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B.
    Sauer A; Letscher-Bru V; Speeg-Schatz C; Touboul D; Colin J; Candolfi E; Bourcier T
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):3950-3. PubMed ID: 20335618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum.
    Tzatzarakis MN; Tsatsakis AM; Charvalos E; Vakalounakis D
    J Environ Sci Health B; 2001 May; 36(3):331-40. PubMed ID: 11411855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm.
    Randhawa MA; Gondal MA; Al-Zahrani AH; Rashid SG; Ali A
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015; 50(2):119-24. PubMed ID: 25560257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antifungal activity of oxygenated cholesterol derivatives.
    Brunel JM; Loncle C; Vidal N; Dherbomez M; Letourneux Y
    Steroids; 2005 Dec; 70(13):907-12. PubMed ID: 16139854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of antifungal polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro.
    Dorocka-Bobkowska B; Konopka K; Düzgüneş N
    Arch Oral Biol; 2003 Dec; 48(12):805-14. PubMed ID: 14596870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetranorditerpene lactones, potent antifungal antibiotics for human pathogenic yeasts, from a unique species of Oidiodendron.
    Hosoe T; Nozawa K; Lumley TC; Currah RS; Fukushima K; Takizawa K; Miyaji M; Kawai K
    Chem Pharm Bull (Tokyo); 1999 Nov; 47(11):1591-7. PubMed ID: 10605057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of MICs of aminocandin for Candida spp. and filamentous fungi.
    Isham N; Ghannoum MA
    J Clin Microbiol; 2006 Dec; 44(12):4342-4. PubMed ID: 17021057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
    Medoff G; Kobayashi GS; Kwan CN; Schlessinger D; Venkov P
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):196-9. PubMed ID: 4550505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-alkylated 2,3,3-trimethylindolenines and 2-methylbenzothiazoles. Potential lead compounds in the fight against Saccharomyces cerevisiae infections.
    Tyler AR; Okoh AO; Lawrence CL; Jones VC; Moffatt C; Smith RB
    Eur J Med Chem; 2013 Jun; 64():222-7. PubMed ID: 23644205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.